Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q3 2018 · 10-Q
Revenue$144.91M$144.91M+12.1% vs Q3 2017 Net Income$16.09M$16.09M+359.7% vs Q3 2017 EPS Diluted$0.57$0.57+338.5% vs Q3 2017 Gross Profit$19,806,000−13.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$20,300,000−23.8% Free Cash Flowderived$2,666,000−79.3% Margins · derivedGross margin13.7%−4.0 pt vs Q3 2017
Operating margin2.4%−0.9 pt vs Q3 2017
Net margin11.1%+8.4 pt vs Q3 2017
ended Feb 25, 2018 · filed Apr 5, 2018 · 39 d after period end